IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q1 2019 Holdings

Filed 2019-05-15 | 14 holdings | $111.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Crispr(CRSP)NAMEN AKTH17182108$41.8K1,171,26837.4%
SientraCommon82621J105$20.5K2,390,84318.3%
Chiasma(CHMA)Common16706W102$10.7K2,080,5959.6%
SolenoCommon834203200$9.6K4,669,2728.6%
Avedro(219)Common05355N109$8.7K719,4027.8%
ParatekCommon699374302$5.6K1,041,1315.0%
Verona(VRNA)SPONDS ADR925050106$5.5K901,9434.9%
Sierra OncologyCommon82640U107$2.3K1,365,0272.1%
Aeglea(AGLEUSD)Common00773J103$1.9K240,5001.7%
Cymabay(CBAYUSD)Common23257D103$1.7K131,0361.6%
ObsevaCommonH5861P103$1.1K87,9991.0%
ProteonCommon74371L109$1.0K2,017,8720.9%
RealmADR75606L103$988255,3710.9%
HistogenicsCommon43358V109$2061,777,7780.2%